We are live on ! Find out more
CERE

Cerevel Therapeutics Holdings, Inc. Common Stock
CERE

Delisted

CERE was delisted on the 31st of July, 2024.

Back to rankings

114 hedge funds and large institutions have $3.78B invested in Cerevel Therapeutics Holdings, Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 59 increasing their positions, 19 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

211% more repeat investments, than reductions

Existing positions increased: 59 | Existing positions reduced: 19

46% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 13

29% more call options, than puts

Call options by funds: $16M | Put options by funds: $12.4M

16% more capital invested

Capital invested by funds: $3.27B → $3.78B (+$517M)

6% more funds holding

Funds holding: 108 → 114 (+6)

33% less funds holding in top 10

Funds holding in top 10: 3 → 2 (-1)

Holders
114
Holders Change
+6
Holders Change %
+5.56%
% of All Funds
1.96%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.03%
New
19
Increased
59
Reduced
19
Closed
13
Calls
$16M
Puts
$12.4M
Net Calls
+$3.61M
Net Calls Change
-$289K

Top Buyers

Rank Fund Capital Flow
1
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$82M
2
PA
Perceptive Advisors
New York
+$42.4M
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$31.9M
4
Point72 Asset Management
Point72 Asset Management
Connecticut
+$26.3M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$25.7M

Top Sellers

Rank Fund Capital Flow
1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$45.5M
2
EC
EcoR1 Capital
California
-$43.5M
3
Citadel Advisors
Citadel Advisors
Florida
-$11.9M
4
ABG
Ally Bridge Group
New York
-$4.5M
5
N
Nuveen
North Carolina
-$2.06M
Name Holding Trade Value Shares
Change 		Change in
Stake
BNP Paribas Financial Markets
51
BNP Paribas Financial Markets
France
$1.75M +$1.85M +61,985 New
State of Wisconsin Investment Board
52
State of Wisconsin Investment Board
Wisconsin
$1.68M +$238K +7,993 +16%
First Trust Advisors
53
First Trust Advisors
Illinois
$1.67M +$660K +22,175 +60%
Susquehanna International Group
54
Susquehanna International Group
Pennsylvania
$1.63M +$1.49M +50,194 +658%
Legal & General Group
55
Legal & General Group
United Kingdom
$1.45M +$135K +4,531 +10%
CS
56
Credit Suisse
Switzerland
$1.42M +$45.7K +1,533 +3%
UBS AM
57
UBS AM
Illinois
$1.41M -$364K -12,227 -20%
Hudson Bay Capital Management
58
Hudson Bay Capital Management
Connecticut
$1.27M +$1.34M +45,000 New
New York State Common Retirement Fund
59
New York State Common Retirement Fund
New York
$1.16M +$93.7K +3,146 +8%
PVI
60
Pura Vida Investments
New York
$1.16M +$1.23M +41,136 New
TC
61
TwinBeech Capital
New York
$1.1M +$1.16M +39,072 New
BFM
62
Boothbay Fund Management
New York
$960K +$1.01M +33,959 New
CSS
63
Cubist Systematic Strategies
Connecticut
$938K +$989K +33,207 New
MIM
64
MetLife Investment Management
New Jersey
$815K – – –
Prudential Financial
65
Prudential Financial
New Jersey
$773K +$322K +10,800 +65%
AIG
66
American International Group
New York
$729K +$10.9K +365 +1%
Principal Financial Group
67
Principal Financial Group
Iowa
$715K -$387 -13 -0.1%
Deutsche Bank
68
Deutsche Bank
Germany
$704K -$217K -7,288 -23%
AQR Capital Management
69
AQR Capital Management
Connecticut
$675K +$36.8K +1,237 +5%
SEI Investments
70
SEI Investments
Pennsylvania
$668K +$373K +12,520 +112%
HS
71
HighVista Strategies
Massachusetts
$667K -$144K -4,839 -17%
Invesco
72
Invesco
Georgia
$643K +$49.3K +1,654 +8%
Mirae Asset Global Investments
73
Mirae Asset Global Investments
South Korea
$640K +$208K +6,970 +44%
VOYA Investment Management
74
VOYA Investment Management
Georgia
$593K +$14.8K +496 +2%
Verition Fund Management
75
Verition Fund Management
Connecticut
$550K +$579K +19,457 New
1 2
3
4 5

CERE Hedge Fund Activity: Q3 2022 in Review

114 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) for Q3 2022, worth a combined $3.78B — up 16% from $3.27B a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new CERE positions and 13 closed out — a net gain of 6 holders — while 59 added to existing stakes and 19 trimmed.

The largest buyer was Janus Henderson Group, adding an estimated $82M. The largest seller was T. Rowe Price Associates, cutting an estimated $45.5M.

  • 114 institutional investors held Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) as of Q3 2022, up from 108 in Q2 2022.
  • Funds reported $3.78B of Cerevel Therapeutics Holdings, Inc. Common Stock stock for Q3 2022, up 16% quarter-over-quarter.
  • 19 funds opened new Cerevel Therapeutics Holdings, Inc. Common Stock positions in Q3 2022 and 13 closed out, a net change of +6 holders.
  • The largest Cerevel Therapeutics Holdings, Inc. Common Stock buyer in Q3 2022 was Janus Henderson Group, an estimated $82M added.
  • The largest Cerevel Therapeutics Holdings, Inc. Common Stock seller in Q3 2022 was T. Rowe Price Associates, an estimated $45.5M sold.

Based on aggregated 13F filings for Q3 2022.